Optovue   Report issue

For profit Phase 4
Founded: Fremont CA United States (2003)
Status: No NME R&D (2003)

Organization Overview

First Clinical Trial
2017
NCT03323164
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Optovue